XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Cover Page - shares
6 Months Ended
Jun. 30, 2019
Jul. 30, 2019
Cover page.    
Entity Central Index Key 0001576263  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2019  
Document Transition Report false  
Entity File Number 001-35921  
Entity Registrant Name Mirati Therapeutics, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-2693615  
Entity Address, Address Line One 9393 Towne Centre Drive, Suite 200  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92121  
City Area Code 858  
Local Phone Number 332-3410  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol MRTX  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   39,296,117